Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response

BACKGROUND: Adjunctive minocycline shows promise in treating affective and psychotic disorders; however, the therapeutic mechanism remains unclear. Identifying relevant biomarkers may enhance the efficacy of novel adjunctive treatment candidates. We thus investigated the peripheral immune-inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Adam J., Mohebbi, Mohammadreza, Maes, Michael, Berk, Michael, Walder, Ken, Bortolasci, Chiara C., Liu, Zoe SJ., Ng, Chee H., Ashton, Melanie M., Berk, Lesley, Singh, Ajeet B., Malhi, Gin S., Dean, Olivia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826878/
https://www.ncbi.nlm.nih.gov/pubmed/36632339
http://dx.doi.org/10.1016/j.bbih.2022.100581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826878/
https://www.ncbi.nlm.nih.gov/pubmed/36632339
http://dx.doi.org/10.1016/j.bbih.2022.100581

Ejemplares similares